Iridex Cp (IRIX) 15.86 $IRIX Shares of IRIX Up 60.7%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Iridex Cp (IRIX) 15.86 $IRIX

Shares of IRIX Up 60.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jul 08, 12:21AM CDT
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on February 26th, 2016 at $9.93. In approximately 4 months, Iridex has returned 60.73% as of today's recent price of $15.96.
IRIX: 15.86 (-0.10)

Shares of IRIX Up 49.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jun 30, 12:54PM CDT
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on February 26th, 2016 at $9.93. In approximately 4 months, Iridex has returned 49.85% as of today's recent price of $14.88.
IRIX: 15.86 (-0.10)

Iridex Has Returned 48.7% Since SmarTrend Recommendation (IRIX)
Comtex SmarTrend(R) - Thu Jun 23, 12:29AM CDT
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on February 26th, 2016 at $9.93. In approximately 4 months, Iridex has returned 48.74% as of today's recent price of $14.77.
IRIX: 15.86 (-0.10)

Iridex Up 41.4% Since SmarTrend Uptrend Call (IRIX)
Comtex SmarTrend(R) - Wed Jun 08, 12:39AM CDT
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on February 26th, 2016 at $9.93. In approximately 3 months, Iridex has returned 41.39% as of today's recent price of $14.04.
IRIX: 15.86 (-0.10)

IRIDEX to Present at the Singular Research 11th Annual Best of the Uncovereds Spring Select Conference
PR Newswire - Thu Jun 02, 3:05PM CDT
IRIDEX Corporation (Nasdaq:IRIX), a leading global provider of innovative laser systems, delivery devices and consumables in ophthalmology, today announced that President and CEO Will Moore is scheduled to present at the Singular Research 11th Annual Best of the Uncovereds Spring Select Conference on Thursday, June 9, 2016, at 1:45 pm PT in San Francisco.
IRIX: 15.86 (-0.10)

Iridex Up 38.3% Since SmarTrend Uptrend Call (IRIX)
Comtex SmarTrend(R) - Tue May 31, 1:04PM CDT
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on February 26th, 2016 at $9.93. In approximately 3 months, Iridex has returned 38.27% as of today's recent price of $13.73.
IRIX: 15.86 (-0.10)

IRIDEX Announces Cyclo G6(TM) with MicroPulse® P3 Clinical Data Presented at ARVO and ASCRS Annual Meetings
PR Newswire - Tue May 10, 6:00AM CDT
IRIDEX Corporation (Nasdaq: IRIX), a leading global provider of innovative laser systems, delivery devices and consumables in ophthalmology, today announced that data on its MicroPulse® P3 device powered by the Cyclo G6(TM) Glaucoma Laser System was presented at both the Association for Research in Vision and Ophthalmology (ARVO) 2016 Annual Meeting from May 1-5 in Seattle and the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting 2016 from May 6-10 in New Orleans.
IRIX: 15.86 (-0.10)

Iridex posts 1Q profit
Automated Insights - Thu May 05, 5:24PM CDT
MOUNTAIN VIEW, Calif. (AP) _ Iridex Corp. (IRIX) on Thursday reported first-quarter earnings of $101,000.
IRIX: 15.86 (-0.10)

IRIDEX Reports 2016 First Quarter Results
PR Newswire - Thu May 05, 3:05PM CDT
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 2, 2016.
IRIX: 15.86 (-0.10)

IRIDEX Announces First Quarter 2016 Conference Call and Release Date
PR Newswire - Thu Apr 28, 3:05PM CDT
IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its first quarter 2016 financial results after the market closes on Thursday, May 5, 2016. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, May 5, 2016 to discuss the results of the quarter and other business developments.
IRIX: 15.86 (-0.10)

IRIDEX Reports 2015 Fourth Quarter, Full Year Results
PR Newswire - Thu Mar 03, 3:05PM CST
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended January 2, 2016.
IRIX: 15.86 (-0.10)

IRIDEX Announces Preliminary Unaudited Revenues for 2015 Fourth Quarter and Full Year
PR Newswire - Mon Jan 11, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) today reported preliminary revenues of approximately $11.9 to $12.2 million and $41.5 to $41.8 million for the fourth quarter and full year 2015, respectively.
IRIX: 15.86 (-0.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 16

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 15

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Mintos Aims for ECB Banking Licence: What’s the Game Plan?

Updated Category News Views 152

Mintos just jumped into the deep end of the pool by chasing a banking license from the European Central Bank (ECB). This move isn’t just window dressing; it’s about shaking up investor confidence and scaling their game. Founded as a peer-to-peer lending marketplace ten years ago, Mintos has morphed into a multi-asset investment platform boasting nearly 700,000...

Continue Reading
Rubin and Rudman Celebrates Jason Webber's Recent Honor

Updated Category News Views 368

Celebrating Excellence in Construction Law Rubin and Rudman recently announced a significant recognition within their legal team. Jason Webber, a distinguished partner in the firm’s Real Estate and Construction groups, has been honored as a 2025 "Go To Construction Lawyer" by Massachusetts Lawyers Weekly. This accolade highlights his exemplary contributions and...

Continue Reading
Costa Rica's Digital Identity Boosts Sustainable Growth

Updated Category News Views 217

Costa Rica's Digital Identity Boosts Global Presence A recent analysis sheds light on Costa Rica's impressive growth in digital presence, fueled by increasing interest in tourism and exports. A study reveals significant online searches, showcasing how effectively the nation has captured the global market’s attention. Growth in Tourism and Exports The report indicates...

Continue Reading
Alorica's Vision for 2025: Customer Experience Transformation

Updated Category News Views 1836

Alorica's Ambitious 2025 Vision for Customer Experience Alorica Inc., a leader in the realm of customer experience (CX), is ready to enter 2025 with a strong foundation built on remarkable achievements from 2024. With a focus on innovation, Alorica aims to enhance how brands interact with their customers. The journey they've undertaken includes the implementation of agent...

Continue Reading
Nikola Corporation Faces Setbacks as Stock Hits Year Low

Updated Category News Views 135

Nikola Corporation Faces Challenges as Stock Hits Year Low Nikola Corporation (NASDAQ: NKLA) is recognized for its pioneering efforts in electric and hydrogen-powered trucks. Recently, the company's stock experienced a significant downturn, reaching a 52-week low of $1.08. This decline emphasizes the struggles Nikola faces in a competitive market, with its current market...

Continue Reading